Skip to content

DR. BART DE KEYZER

Active Private limited companyfounded 2018active for 8 yearsBlekkenbergstraat 31, 3570 AlkenKBO/BCE: BE 0695.904.427

Lifetime

8 annual accounts with figures on one time axis
peak of €407,674 in 2023
€313,439▲ 9.3%
peak of €290,132 in 2023
€219,966▲ 10.0%
peak of €776,918 in 2020
€18,600unchanged
€246,106▲ 6.7%
Board1 name since 2018
1 director
Documentsfilings and deeds
06-03-2026147 days before the deadline
2025micro format
Dividend €219,966Cash from €183,038 to €47,669

Key points

from the 2025 annual accounts

Equity

€18,600 from €776,918 in 2020

Equity fell by 98% in 5 years.

Turnover

≈ €470,000 estimated

The micro format states no turnover.

Debts

€246,106 93% of the balance sheet

Filings

8 annual accounts since 2018
AprilJune31 JulyOctober20202025

The last five annual accounts were filed 25 to 147 days before the end of the period.

Position in the sector

7.0%

Lower solvency than 88% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as DR. BART DE KEYZER has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for DR. BART DE KEYZER. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 14-05-2018
  • 100 sharesdeed of 16-05-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0695904427
Registered office moved from Hasselt to Alken The registered office moved from Beukenhoflaan 41 te 3500 Hasselt to Blekkenbergstraat 31 te 3570 Alken · General meeting of 03-07-2023 · Gazette deed
changes role from manager to director Discharge granted to · General meeting of 06-05-2022 · Gazette deed
Incorporation Founding capital of €18,600, 100 shares, €12,400 paid up · Founded by · appointed as manager · published on 16-05-2018 · Gazette deed
All 16 events

Comparable companies

same main activity, similar in size and age
Company
DR. BART DE KEYZER Alken €264,706 €313,439 7.0% -
Dr. Tom Cornelis Riemst €264,263 €341,566 95.7% -
HENICOL Sint-Truiden €227,454 €291,543 94.6% -
Psychia Mortsel €260,584 €292,486 98.1% -
Dr. Anne-Sophie Vinck Zedelgem €254,305 €298,127 0.8% -
KH MEDICS Ixelles €250,259 €310,532 8.2% -
Dokter Sofie Geth Schoten €274,259 €332,653 97.1% -

These companies have the same main activity as DR. BART DE KEYZER: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €227,000 and €274,000, founded between 2017 and 2018.

Official details

Source: KBO
Status
Active since 14-05-2018Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.275.787.1753570 Alken, registered on 14-05-2018
Financial year end
31 December
Peppol
Reachable since 06-06-2025
Company details

Annual accounts 2025

€264,706▲ 6.2%
Filing
Filed on 06-03-2026, 147 days before the end of the filing period
Financials

Insights on DR. BART DE KEYZER

DR. BART DE KEYZER files the micro format. That format states no turnover. The gross margin rose from €303,933 in 2018 to €313,439 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. BART DE KEYZER

What is the company number of DR. BART DE KEYZER?
The company number of DR. BART DE KEYZER is 0695.904.427. The VAT number is the same number with BE in front: BE 0695.904.427.
Where is DR. BART DE KEYZER based?
The registered office is at Blekkenbergstraat 31, 3570 Alken.Company details
What does DR. BART DE KEYZER do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. BART DE KEYZER?
DR. BART DE KEYZER is a private limited company (BV).
When was DR. BART DE KEYZER founded?
DR. BART DE KEYZER was founded on 14-05-2018.
Is DR. BART DE KEYZER still active?
Yes, DR. BART DE KEYZER is an active enterprise in the KBO register.
What is the turnover of DR. BART DE KEYZER?
The turnover in financial year 2025 is about €470,000. This figure is estimated from the gross margin of €313,439 and 31 comparable companies (NACE 86220). It probably lies between €420,000 and €660,000.Financials
Is DR. BART DE KEYZER profitable?
In financial year 2025, DR. BART DE KEYZER made a profit of €219,966.
Where can I find the annual accounts of DR. BART DE KEYZER?
DR. BART DE KEYZER filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. BART DE KEYZER due?
DR. BART DE KEYZER must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.